X0407 4 2023-04-03 false 0001412408 Phreesia, Inc. PHR 0001756253 Smith Mark Douglas C/O PHREESIA, INC. 1521 CONCORD PIKE, SUITE 301 PMB 221 WILMINGTON DE 19803 true false false false true Common Stock 2023-04-03 4 M false 7000.00 4.71 A 23112.00 D Common Stock 2023-04-03 4 S false 6500.00 30.6895 D 16612.00 D Common Stock 2023-04-03 4 S false 500.00 31.771 D 16112.00 D Stock Option 4.71 2023-04-03 4 M false 7000.00 0.00 D 2028-09-04 Common Stock 7000.00 65193.00 D This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on January 18, 2023. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.33 to $31.19 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.60 to $31.93 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. 27,306 of the original 84,193 shares underlying the option vested became exercisable on September 5, 2019, with 25% of the remainder vesting on September 5, 2019, and 75% of the remainder vesting in thirty-six (36) equal monthly installments thereafter. /s/ Alexis Lyons, as Attorney-in-Fact for Smith Mark Douglas 2023-04-05